Cardiac amyloidosis, did we forget it?

    Authors

    Abstract

    **Background:** Amyloidosis is a heterogeneous group of diseases characterized by the accumulation of protein deposits. Some of them affect the heart, and the most common are the immunoglobulin light chains and transthyretin. (1-3) **Case report:** A patient at the age of 60 is admitted to emergency care due to chest pain. She has been taking medicines for dyslipidemia. Chest X ray in ER (emergency room) described a heart enlargement. As a result of the echocardiography, a preserved left ventricular fraction was observed and thickened wall of both ventricles. Coronarography excluded atherosclerotic changes in epicardial vessels. Further treatment of the patient verified an elevated NT-proBNP of 4055.4 pg/ml and a 24-hour proteinuria of 1.52 g. Electrophoresis of proteins and immunofixation indicates elevated lambda light chains. Bone marrow puncture is performed and multiplying plasma cells (15%) were observed. Due to kidney involvement, the kidney biopsy was performed with a positive pathohistological finding of amyloidosis with lambda light chains. The second patient at the age of 57 is admitted to emergency care due to signs of heart failure. He has a history of Hashimoto’s disease. Chest X ray in ER has described myopathic heart. 12-lead ECG is characterized by non-specific conduction disorders. As a result of the echocardiography, slightly lowered left ventricular fraction was observed and thickened walls of both ventricles. Further tests verified an increased NT-proBNP > 8000 pg/ml. Electrophoresis of proteins and immunofixation indicates elevated kappa light chains. Bone marrow puncture is performed and multiplied plasma cells (9%) were observed. Due to skin lesions of the face, the biopsy was performed with a positive pathohistological finding of amyloidosis with kappa light chains. **Conclusion:** The timely recognition of cardiac amyloidosis is of extreme importance for the treatment and prognosis of the disease. The timely detection of illness provides patients with adequate treatment and significant life extensions.

    Keywords

    amyloidosis, heart failure, echocardiography

    DOI

    https://doi.org/10.15836/ccar2018.374

    Literature

    1. Flodrova P, Flodr P, Pika T, Vymetal J, Holub D, Dzubak P, et al. Cardiac amyloidosis: from clinical suspicion to morphological diagnosis. Pathology. 2018 Apr;50(3):261–8. https://doi.org/10.1016/j.pathol.2017.10.012
    2. Donnelly JP, Hanna M. Cardiac amyloidosis: An update on diagnosis and treatment. Cleve Clin J Med. 2017 Dec;84(12) Suppl 3:12–26. https://doi.org/10.3949/ccjm.84.s3.02
    3. Milani P, Merlini G, Palladini G. Light Chain Amyloidosis. Mediterr J Hematol Infect Dis. 2018 Mar 1;10(1):e2018022. https://doi.org/10.4084/mjhid.2018.022
    Cardiologia Croatica
    Back to search

    Cardiac amyloidosis, did we forget it?

    Extended Abstract
    Issue11-12
    Published
    Pages374
    PDF via DOIhttps://doi.org/10.15836/ccar2018.374
    amyloidosis
    heart failure
    echocardiography

    Authors

    Tomo Svaguša*ORCIDKlinička bolnica Dubrava, Zagreb, Hrvatska
    Boris StarčevićORCIDKlinička bolnica Dubrava, Zagreb, Hrvatska
    Diana RudanORCIDKlinička bolnica Dubrava, Zagreb, Hrvatska

    *Correspondence email: svagusa.tomo@gmail.com

    Abstract

    **Background:** Amyloidosis is a heterogeneous group of diseases characterized by the accumulation of protein deposits. Some of them affect the heart, and the most common are the immunoglobulin light chains and transthyretin. (1-3) **Case report:** A patient at the age of 60 is admitted to emergency care due to chest pain. She has been taking medicines for dyslipidemia. Chest X ray in ER (emergency room) described a heart enlargement. As a result of the echocardiography, a preserved left ventricular fraction was observed and thickened wall of both ventricles. Coronarography excluded atherosclerotic changes in epicardial vessels. Further treatment of the patient verified an elevated NT-proBNP of 4055.4 pg/ml and a 24-hour proteinuria of 1.52 g. Electrophoresis of proteins and immunofixation indicates elevated lambda light chains. Bone marrow puncture is performed and multiplying plasma cells (15%) were observed. Due to kidney involvement, the kidney biopsy was performed with a positive pathohistological finding of amyloidosis with lambda light chains. The second patient at the age of 57 is admitted to emergency care due to signs of heart failure. He has a history of Hashimoto’s disease. Chest X ray in ER has described myopathic heart. 12-lead ECG is characterized by non-specific conduction disorders. As a result of the echocardiography, slightly lowered left ventricular fraction was observed and thickened walls of both ventricles. Further tests verified an increased NT-proBNP > 8000 pg/ml. Electrophoresis of proteins and immunofixation indicates elevated kappa light chains. Bone marrow puncture is performed and multiplied plasma cells (9%) were observed. Due to skin lesions of the face, the biopsy was performed with a positive pathohistological finding of amyloidosis with kappa light chains. **Conclusion:** The timely recognition of cardiac amyloidosis is of extreme importance for the treatment and prognosis of the disease. The timely detection of illness provides patients with adequate treatment and significant life extensions.

    Literature

    1. 1.
      Flodrova P, Flodr P, Pika T, Vymetal J, Holub D, Dzubak P, et al. Cardiac amyloidosis: from clinical suspicion to morphological diagnosis. Pathology. 2018 Apr;50(3):261–8.DOI
    2. 2.
      Donnelly JP, Hanna M. Cardiac amyloidosis: An update on diagnosis and treatment. Cleve Clin J Med. 2017 Dec;84(12) Suppl 3:12–26.DOI
    3. 3.
      Milani P, Merlini G, Palladini G. Light Chain Amyloidosis. Mediterr J Hematol Infect Dis. 2018 Mar 1;10(1):e2018022.DOI